Suriclone for generalized anxiety disorder: an escalating multiple-dose, safety, tolerance, and efficacy study.
D000293:Adolescent; D000328:Adult; D001008:Anxiety Disorders / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009287:Naphthyridines; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use*; D013457:Sulfur Compounds; D013997:Time Factors
D009287:Naphthyridines; D010879:Piperazines; D013457:Sulfur Compounds; C037283:suriclone